Abstract is: Loa loa filariasis is a skin and eye disease caused by the nematode worm Loa loa. Humans contract this disease through the bite of a deer fly or mango fly (Chrysops spp.), the vectors for Loa loa. The adult Loa loa filarial worm migrates throughout the subcutaneous tissues of humans, occasionally crossing into subconjunctival tissues of the eye where it can be easily observed. Loa loa does not normally affect one's vision but can be painful when moving about the eyeball or across the bridge of the nose. The disease can cause red itchy swellings below the skin called "Calabar swellings". The disease is treated with the drug diethylcarbamazine (DEC), and when appropriate, surgical methods may be employed to remove adult worms from the conjunctiva. Loiasis belongs to the so-called neglected diseases.
| infectious disease | Q18123741 |
| class of disease | Q112193867 |
| disease | Q12136 |
| filariasis | Q815753 |
| skin disease | Q949302 |
| eye disease | Q3041498 |
| parasitic eye infection | Q54514255 |
| parasitic skin disease | Q54911414 |
| rare skin disease | Q55788696 |
| P2581 | BabelNet ID | 01118890n |
| 01118890n | ||
| P699 | Disease Ontology ID | DOID:13523 |
| P557 | DiseasesDB | 7576 |
| P673 | eMedicine ID | 2500105 |
| 217776 | ||
| P10565 | Encyclopedia of China (Third Edition) ID | 245495 |
| P1417 | Encyclopædia Britannica Online ID | science/loiasis |
| P2888 | exact match | http://identifiers.org/doid/DOID:13523 |
| http://purl.obolibrary.org/obo/DOID_13523 | ||
| http://www.orpha.net/ORDO/Orphanet_2404 | ||
| P11956 | Experimental Factor Ontology ID | 1000729 |
| P646 | Freebase ID | /m/019j95 |
| P4317 | GARD rare disease ID | 3283 |
| P4229 | ICD-10-CM | B74.3 |
| P7807 | ICD-11 (foundation) | 709184369 |
| P7329 | ICD-11 ID (MMS) | 1F66.0 |
| P1692 | ICD-9-CM | 125.2 |
| P3827 | JSTOR topic ID | loiasis |
| P665 | KEGG ID | H01104 |
| P486 | MeSH descriptor ID | D008118 |
| P672 | MeSH tree code | C01.610.335.508.700.750.361.518 |
| P6366 | Microsoft Academic ID | 2780895566 |
| P5270 | Mondo ID | MONDO_0016566 |
| P1748 | NCI Thesaurus ID | C34784 |
| P1550 | Orphanet ID | 2404 |
| P2892 | UMLS CUI | C0023968 |
| P11143 | WikiProjectMed ID | Loa loa filariasis |
| P1889 | different from | Loase | Q22644161 |
| P1060 | disease transmission process | insect borne transmission | Q15304529 |
| P828 | has cause | Loa loa | Q134361 |
| P1995 | health specialty | infectious diseases | Q788926 |
| tropical medicine | Q1365243 | ||
| P5008 | on focus list of Wikimedia project | WikiProject Medicine | Q4099686 |
| P924 | possible treatment | diethylcarbamazine | Q409267 |
| P780 | symptoms and signs | pain | Q81938 |
| edema | Q152234 | ||
| abscess | Q164655 |
| Q46465319 | A Case of loiasis in a patient returning to China diagnosed by nested PCR using DNA extracted from tissue. |
| Q35530636 | A brief review of recent advances in our knowledge of loiasis and of some of the still outstanding problems |
| Q39271098 | A case of loiasis in Rome. |
| Q38869135 | A historical note on an imported case of loiasis in Rio de Janeiro, Brazil, 1964. |
| Q44516650 | A patient with loiasis following a trip to Central Africa |
| Q50730891 | A trial of banocide as a means of controlling the transmission of loiasis on a rubber estate in Nigeria. |
| Q50610297 | Adverse reactions from community directed treatment with ivermectin (CDTI) for onchocerciasis and loiasis in Ondo State, Nigeria. |
| Q70770548 | Albendazole in human loiasis: results of a double-blind, placebo-controlled trial |
| Q73104950 | Albendazole therapy for loiasis refractory to diethylcarbamazine treatment |
| Q28294770 | Anti-Wolbachia drug discovery and development: safe macrofilaricides for onchocerciasis and lymphatic filariasis |
| Q43170625 | Apheresis in the management of loiasis with high microfilariaemia and renal disease |
| Q35062278 | Assessment of loiasis and outcomes of ivermectin masstreatment in Ijebu-North, Nigeria |
| Q91156738 | Atypical Clinical Manifestations of Loiasis and Their Relevance for Endemic Populations |
| Q96680303 | Burden of disease in Gabon caused by loiasis: a cross-sectional survey |
| Q87313841 | Calcification in loiasis |
| Q36714597 | Calcification of the breasts due to loiasis |
| Q88612306 | Case Report: Probable Case of Spontaneous Encephalopathy Due to Loiasis and Dramatic Reduction of Loa loa Microfilariaemia with Prolonged Repeated Courses of Albendazole |
| Q34875613 | Case report: Loiasis with peripheral nerve involvement and spleen lesions |
| Q40831256 | Challenges for the future: loiasis |
| Q99760750 | Challenges for the future: loiasis |
| Q35287048 | Chronic symptomatic and microfilaremic loiasis in a returned traveller |
| Q43675687 | Chrysops silacea and C.dimidiata seasonality and loiasis prevalence in the Chaillu mountains, Congo |
| Q47887123 | Chrysops silacea biting densities and transmission potential in an endemic area of human loiasis in south-west Cameroon |
| Q36026551 | Clinical Features of Imported Loiasis: A Case Series from the Hospital for Tropical Diseases, London |
| Q38947198 | Clinical and laboratory features of patients with loiasis (Loa loa filariasis) in the U.K. |
| Q44642905 | Clinical manifestations of loiasis in an endemic area in the Congo |
| Q35219707 | Co-endemicity of loiasis and onchocerciasis in rain forest communities in southwestern Nigeria |
| Q46551749 | Co-endemicity of loiasis and onchocerciasis in the South West Province of Cameroon: implications for mass treatment with ivermectin |
| Q24800164 | Combined Utilisation of Rapid Assessment Procedures for Loiasis (RAPLOA) and Onchocerciasis (REA) in Rain forest Villages of Cameroon |
| Q28476179 | Community-directed delivery of doxycycline for the treatment of onchocerciasis in areas of co-endemicity with loiasis in Cameroon |
| Q46261481 | Comparative analysis of 2 diagnostic methods of human loiasis: IgG4 serology and nested PCR |
| Q75685116 | Destruction of microfilariae of Loa loa in the liver in loiasis treated with banocide (hetrazan) |
| Q39442028 | Diagnosing multiple parasitic infections: trypanosomiasis, loiasis and schistosomiasis in a single case |
| Q69937260 | Diethylcarbamazine and human loiasis |
| Q46715937 | Differential recognition of Loa loa antigens by sera of human subjects from a loiasis endemic zone. |
| Q46624158 | Ecology of human loiasis in Nigeria |
| Q46724643 | Effectiveness of diethylcarbamazine in treating loiasis acquired by expatriate visitors to endemic regions: long-term follow-up |
| Q91919848 | Efficacy of High-Dose Albendazole with Ivermectin for Treating Imported Loiasis, Italy |
| Q91060617 | Encephalopathy in a patient with loiasis treated with albendazole: A case report |
| Q34974564 | Eosinophil-associated processes underlie differences in clinical presentation of loiasis between temporary residents and those indigenous to Loa-endemic areas |
| Q38943579 | Excess mortality associated with loiasis: a retrospective population-based cohort study |
| Q68208462 | Failure of high dose mebendazole as a microfilaricide in patients with loiasis |
| Q28327286 | Five cases of encephalitis during treatment of loiasis with diethylcarbamazine |
| Q39577904 | Heterogeneity in the prevalence and intensity of loiasis in five contrasting bioecological zones in Cameroon |
| Q45015267 | Human loiasis in a Cameroonian village: A double-blind, placebo-controlled, crossover clinical trial of a three-day albendazole regimen |
| Q50632375 | Human occult loiasis: field evaluation of a nested polymerase chain reaction assay for the detection of occult infection. |
| Q44655752 | Human occult loiasis: improvement in diagnostic sensitivity by the use of a nested polymerase chain reaction. |
| Q46795862 | IgG4 serology of loiasis in three villages in an endemic area of south-eastern Gabon |
| Q85043581 | Images in clinical medicine. Ocular loiasis |
| Q68091106 | Immunologic correlates of the hyperresponsive syndrome of loiasis |
| Q104484463 | Immunomodulatory Therapy for the Management of Loiasis |
| Q58723511 | Impact of repeated annual community directed treatment with ivermectin on loiasis parasitological indicators in Cameroon: Implications for onchocerciasis and lymphatic filariasis elimination in areas co-endemic with Loa loa in Africa |
| Q37362005 | Impact of repeated ivermectin treatments against onchocerciasis on the transmission of loiasis: an entomologic evaluation in central Cameroon |
| Q91695904 | Implementation of test-and-treat with doxycycline and temephos ground larviciding as alternative strategies for accelerating onchocerciasis elimination in an area of loiasis co-endemicity: the COUNTDOWN consortium multi-disciplinary study protocol |
| Q92777536 | Imported loiasis in France: a retrospective analysis of 167 cases with comparison between sub-Saharan and non sub-Saharan African patients |
| Q38137557 | Imported loiasis in France: a retrospective analysis of 47 cases |
| Q39025698 | Imported loiasis in Italy: an analysis of 100 cases |
| Q54008610 | Imported loiasis in Rhodesia |
| Q53682038 | In Southern Nigeria Loa loa Blood Microfilaria Density is Very Low Even in Areas with High Prevalence of Loiasis: Results of a Survey Using the New LoaScope Technology. |
| Q55334206 | Increasing evidence of low lymphatic filariasis prevalence in high risk Loa loa areas in Central and West Africa: a literature review. |
| Q77873489 | Infectious diseases: filariasis, Malayan filariasis, loiasis (ioa ioa), Onchocerciasis (river blindness) |
| Q43930924 | Integrated rapid mapping of onchocerciasis and loiasis in the Democratic Republic of Congo: impact on control strategies |
| Q54963442 | Integrated risk mapping and landscape characterisation of lymphatic filariasis and loiasis in South West Nigeria. |
| Q39396872 | Ivermectin in loiasis and concomitant O. volvulus and M. perstans infections |
| Q34321712 | Loa loa ecology in central Africa: role of the Congo River system |
| Q30844358 | Loa loa vectors Chrysops spp.: perspectives on research, distribution, bionomics, and implications for elimination of lymphatic filariasis and onchocerciasis |
| Q46327245 | Loiasis (a case report). |
| Q46605942 | Loiasis 15 years after exposure |
| Q59291490 | Loiasis and Mansonella Infections |
| Q59291545 | Loiasis and Mansonella Infections |
| Q70946912 | Loiasis and renal failure |
| Q46447211 | Loiasis in Ijebu Division, West Nigeria |
| Q43812110 | Loiasis in Maryland |
| Q42345369 | Loiasis in US Traveler Returning from Bioko Island, Equatorial Guinea, 2016 |
| Q40625799 | Loiasis in Westchester County |
| Q35817720 | Loiasis in a Japanese Traveler Returning from Central Africa |
| Q46504890 | Loiasis in a young child in Oregon |
| Q46584145 | Loiasis in an American naturalist. |
| Q46197861 | Loiasis in an expatriate American child: diagnostic and treatment difficulties. |
| Q41186005 | Loiasis in endemic and nonendemic populations: immunologically mediated differences in clinical presentation |
| Q89579759 | Loiasis in sub-Saharan migrants living in Spain with emphasis of cases from Equatorial Guinea |
| Q80355022 | Loiasis treated with hetrazan |
| Q46875709 | Loiasis with pleural and peritoneal involvement |
| Q40179855 | Loiasis, a Subconjunctival Manifestation. |
| Q45035791 | Loiasis, a cause of eosinophilia to consider |
| Q69839280 | Loiasis: "Calabar" swellings and involvement of deep organs |
| Q34777473 | Loiasis: African eye worm |
| Q68030770 | Loiasis: a case of an unusual ocular foreign body |
| Q50707881 | Loiasis: a case report |
| Q83981897 | Loiasis: new epidemiologic insights and proposed treatment strategy |
| Q39023024 | Loiasis: report of three cases and literature review |
| Q43471045 | Loiasis: the individual factors associated with the presence of microfilaraemia |
| Q64117711 | Mapping of lymphatic filariasis in loiasis areas: A new strategy shows no evidence for Wuchereria bancrofti endemicity in Cameroon |
| Q58993360 | Markers of Loa loa infection in permanent residents of a loiasis endemic area of Gabon |
| Q46177877 | Market survey of loiasis: prevalence and adverse reactions to ivermectin using a rapid procedure for loiasis. |
| Q73517704 | Microfilarial clearance in loiasis involves elevation of Th1 and Th2 products and emergence of a specific pattern of T-cell populations |
| Q34399170 | Nephrotic syndrome due to loiasis following a tropical adventure holiday: a case report and review of the literature. |
| Q97528152 | Nonsurgical management of photoaversive ocular and systemic loiasis in Michigan |
| Q69416677 | Occular loiasis in a Zambian woman |
| Q92112505 | Ocular loiasis affecting a child and its assessment by Anterior Segment Optical Coherence Tomography |
| Q35227253 | Ocular loiasis in London 2008-2009: a case series |
| Q40114466 | Ocular loiasis in Ohio: a case report |
| Q43777323 | Ocular loiasis in a patient with chronic hypereosinophilia |
| Q28550781 | Parasitological, Hematological and Biochemical Characteristics of a Model of Hyper-microfilariaemic Loiasis (Loa loa) in the Baboon (Papio anubis) |
| Q95845534 | Performance of two serodiagnostic tests for loiasis in a Non-Endemic area |
| Q77402911 | Photo quiz. Loiasis |
| Q52608487 | Potential vectors of loiasis and other tabanids on the island of Bioko, Equatorial Guinea. |
| Q45227778 | Prevalences of loiasis in Ondo state, Nigeria, as evaluated by the rapid assessment procedure for loiasis (RAPLOA). |
| Q28553109 | Protein Translation Enzyme lysyl-tRNA Synthetase Presents a New Target for Drug Development against Causative Agents of Loiasis and Schistosomiasis |
| Q27306767 | Pulmonary loiasis and HIV coinfection in rural Cameroon |
| Q34526206 | Rapid assessment procedure for loiasis and mapping lymphatic filariasis: two perfect illustrations of "to be in English or not to be". |
| Q67471561 | Rheumatoid factor and rheumatoid factor isotypes in loiasis with and without accompanying glomerulonephritis |
| Q77164638 | STUDIES ON LOIASIS IN MONKEYS. IV. EXPERIMENTAL HYBRIDIZATION OF THE HUMAN AND SIMIAN STRAINS OF LOA |
| Q46920888 | STUDIES ON THE CONTROL OF THE VECTORS OF LOIASIS IN WEST AFRICA. III. COMPARISON OF THE TOXICITIES OF DDT, DIELDRIN, ALDRIN AND GAMMA-BHC TO LATE-INSTAR TABANID LARVAE. |
| Q46937458 | STUDIES ON THE CONTROL OF THE VECTORS OF LOIASIS IN WEST AFRICA. IV. THE PERSISTENCE OF DDT, DIELDRIN, ALDRIN AND GAMMA-BHC IN THE MUD OF NATURAL TABANID BREEDING-SITES IN THE RAIN-FOREST OF THE CAMEROONS |
| Q52629999 | STUDIES ON THE CONTROL OF THE VECTORS OF LOIASIS IN WEST AFRICA. V. THE EFFECTS OF DDT, DIELDRIN, ALDRIN AND GAMMA-BHC IN THE MUD OF NATURAL TABANID BREEDING-SITES IN THE RAIN-FOREST OF THE CAMEROONS. |
| Q76675050 | STUDIES ON THE CONTROL OF THE VECTORS OF LOIASIS IN WEST AFRICA. VI. THE EFFECTS OF WATER EMULSIONS OF DIELDRIN ON LATE-INSTAR CHRYSOPS LARVAE IN THE LABORATORY |
| Q52632090 | STUDIES ON THE CONTROL OF THE VECTORS OF LOIASIS IN WEST AFRICA. VII. THE EFFECT OF LOW CONCENTRATIONS OF DIELDRIN IN THE MUD OF NATURAL TABANID BREEDING-SITES IN THE RAIN-FOREST OF THE CAMEROONS. |
| Q78664162 | SYMPOSIUM on loiasis |
| Q40690708 | Secondary effects of the treatment of hypermicrofilaremic loiasis using ivermectin |
| Q39144366 | Short- and long-term action of multiple doses of ivermectin on loiasis microfilaremia |
| Q104496233 | Slithering Through the Bone Marrow: Loiasis in a Patient With Human T-Cell Leukemia Virus-1-Associated Adult T-Cell Lymphoma |
| Q79107830 | Studies on Ethiopian Chrysops as possible vectors of loiasis. II. Chrysops silacea Austen and human loiasis |
| Q46300179 | Studies on loiasis in monkeys. I. The relationship between human and simian Loa in the rain-forest zone of the British Cameroons. |
| Q79220000 | Studies on loiasis in monkeys. II.--The population dynamics of the microfilariae of Loa in experimentally infected drills (Mandrillus leucophaeus) |
| Q78928604 | Studies on loiasis in monkeys. III. The pathology of the spleen in drills (Mandrillus leucophaeus) infected with Loa |
| Q99759859 | Studies on the Ghemoprophylaxis of Loiasis |
| Q46430826 | Studies on the control of the vectors of loiasis in West Africa. 8. An attempt to control loiasis at Kumba, West Cameroon |
| Q52628827 | Studies on the control of the vectors of loiasis in West Africa. I. Introduction. |
| Q52628384 | Studies on the control of the vectors of loiasis in West Africa. II. The effect of clearing vegetation from tabanid breeding-places. |
| Q46318752 | Studies on the control of the vectors of loiasis in West Africa. IX. Some conclusions drawn from the attempt to control loiasis at Kumba, West Cameroon. |
| Q34531097 | Subconjunctival loiasis |
| Q59000726 | The Epidemiological Implications of Deer Fly Nuisance Biting and Transmission of Loiasis in an Endemic Area in Southeastern Nigeria |
| Q74569128 | The complement-fixation reaction in loiasis and Acanthocheilonema perstans infections |
| Q33955423 | The geographic distribution of Loa loa in Africa: results of large-scale implementation of the Rapid Assessment Procedure for Loiasis (RAPLOA) |
| Q38894943 | The histopathology of ocular loiasis in Uganda |
| Q43610602 | The occurrence of loiasis, mansonellosis and wuchereriasis in the Jarawa River Valley, central Nigeria |
| Q50732325 | The problem of loiasis in West Africa with special reference to recent investigations at Kumba in the British Cameroons and at Sapele in Southern Nigeria. |
| Q41055944 | The relationship between microfilaraemic and amicrofilaraemic loiasis involving co-infection with Mansonella perstans and clinical symptoms in an exposed population from Gabon |
| Q41575110 | The results of a preliminary entomological survey of loiasis at Kumba, British Cameroons, together with a description of the breeding-places of the sector and suggestions for future research and possible methods of control |
| Q43568610 | The transmission of loiasis in the forest-fringe area of the British Cameroons |
| Q46362022 | Therapeutic trial with ivermectin in loiasis with medium and high microfilaremia |
| Q78936288 | Therapeutic trials of Mel W in onchocerciasis and loiasis |
| Q62491859 | Traveller's loiasis in Zimbabwe: a case report |
| Q73892513 | Two cases of loiasis with peripheral nerve involvement |
| Q96680306 | Uncovering the burden of loiasis: first estimates from Gabon |
| Q72723636 | Unexplained foreign body sensation: Thinking of loiasis in at risk patients prevents significant morbidity |
| Q35797858 | Validation of the rapid assessment procedure for loiasis (RAPLOA) in the Democratic Republic of Congo |
| Q57219334 | [A case of calabar swelling suspected as loiasis] |
| Q53894307 | [Association between loiasis and onchocercosis in Central Africa] |
| Q74271448 | [Bilateral subconjunctival foreign bodies. Loiasis with bilateral Loa ophthalmia] |
| Q52551509 | [Ivermectin and loiasis: a Central African experience] |
| Q93137038 | [Loiasis: A tropical parasitosis in the Primary Care Clinic] |
| Q45898258 | [Preliminary results about loiasis in the district of Likouala in the Republic of the Congo]. |
| Q52552306 | [Severe secondary reactions related to ivermectin treatment in patients with loiasis] |
| Q86841022 | [Subconjunctival Loiasis: case reports and review of cases described in Italy] |
| Q88214495 | [Subconjunctival loiasis: A case report] |
| Q53476906 | [Subconjunctival loiasis: a case report]. |
| Q22644161 | Loase | different from | P1889 |
| Category:Loa loa filariasis | wikimedia | |
| Arabic (ar / Q13955) | داء اللوائيات | wikipedia |
| Catalan (ca / Q7026) | Loaiasi | wikipedia |
| Loiasis | wikipedia | |
| Loa loa filariasis | wikipedia | |
| Basque language (eu / Q8752) | Loa loagatiko infekzio | wikipedia |
| Persian (fa / Q9168) | لوا لوا فیلاریازیس | wikipedia |
| Loase | wikipedia | |
| Hausa language (ha / Q56475) | Cutar filariasis | wikipedia |
| Լոաոզ | wikipedia | |
| Лоаоз | wikipedia | |
| 로아사상충증 | wikipedia | |
| oc | Loa (vèrm) | wikipedia |
| Loajoza | wikipedia | |
| Loaíase | wikipedia | |
| Loază | wikipedia | |
| Лоаоз | wikipedia | |
| Лоаоз | wikipedia |
Search more.